GlucoTrack Inc. (NASDAQ: GCTK)
$0.2540
-0.0100 ( -2.31% ) 40.2K
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
Market Data
Open
$0.2540
Previous close
$0.2640
Volume
40.2K
Market cap
$3.83M
Day range
$0.2550 - $0.2740
52 week range
$0.2012 - $4.9500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Dec 17, 2024 |
def | Proxies and info statements | 3 | Dec 06, 2024 |
8-k | 8K-related | 15 | Dec 03, 2024 |
3 | Insider transactions | 2 | Nov 22, 2024 |
pre | Proxies and info statements | 3 | Nov 22, 2024 |
8-k | 8K-related | 14 | Nov 18, 2024 |
10-q | Quarterly Reports | 46 | Nov 14, 2024 |
8-k | 8K-related | 21 | Nov 14, 2024 |
8-k | 8K-related | 14 | Nov 13, 2024 |
8-k | 8K-related | 15 | Oct 22, 2024 |